Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real Assets

Currenta valued with an attractive enterprise value of EUR 3.5 billion (100%)

Source: Bayer Company News - August 6, 2019 Category: Pharmaceuticals Source Type: news